Advertisment
|
|
|
news roundup
Patient information is encrypted and stored safely, and both patients and investigators can opt out of the service at any time.
The acquisition of PMG Research is intended to enhance ICON’s ability to access and engage with investigator sites and patients through its network of 48 physician practices and large multi-specialty healthcare institutions throughout North Carolina, South Carolina, Tennessee and Illinois.
EORTC's Screening Patients for Efficient Clinical Trial Access (SPECTA) is a pan-European clinical trial site and cancer patient molecular screening network established by EORTC in collaboration with more than 30 leading cancer treatment centers in 11 European countries
One goal of the WCG Foundation is to make IRB review more affordable for patients who are desperate to gain access to experimental treatments.
Quintiles' contribution to ResearchKit should enable the apps it produces with the framework to further engage patients participating in clinical research.
|
|
|
|
advertisment
Advanced Visual Analytics for Efficient Risk Based Monitoring
On Demand
In this webinar, Saritta Hines, Principal Clinical Programmer at Allergan, will present how PerkinElmer's Solution for Clinical Development Operations—powered by TIBCO Spotfire®—is the ideal platform for RBM enabling optimal trial oversight through real-time risk assessment. She will show how to incorporate Key Risk Indicators into interactive dashboards and use advanced TIBCO Spotfire® features including property controls, map features and the embedding of dashboards into responsive web pages.
 Learn more
|
|
Advertisment
|
|
|
article
Accruing patients depends greatly on engaged, enthusiastic PIs, as they are the gatekeepers in helping patients decide to participate in clinical trials.
|
|
|
blog posts
A lack of analytics and measurement metrics for patient engagement is needed to help measure success of patient centric initiatives.
ePRO introduces additional complexity to navigate within the often-subjective area of patient advocacy that IRBs are in place to ensure.
|
|
|
Advertisment
|
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
|
|
